Free Trial
→ Many investors are about to lose everything (From Porter & Company) (Ad)tc pixel
OTCMKTS:EKTAY

Elekta Q4 2025 Earnings Results & Report

Elekta logo
$6.23 +0.04 (+0.57%)
As of 11/11/2026 02:28 PM Eastern

Elekta missed analyst expectations on both earnings and revenue in its Q4 2025 results, released May 28, 2025. The company reported EPS of $0.11 versus the $0.13 consensus estimate, while revenue of $503.22 million fell short of the $507.19 million estimate by $3.97 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
Before Market Opens

Elekta EPS Results

Actual EPS
$0.11
Consensus EPS
$0.13
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

Elekta Revenue Results

Actual Revenue
$503.22 million
Expected Revenue
$507.19 million
Beat/Miss
Missed by -$3.97 million
YoY Revenue Growth
N/A

Upcoming Earnings

Elekta's next earnings date is estimated for Wednesday, November 25, 2026, based on past reporting schedules.

Conference Call Resources

Elekta Q4 2025 Earnings FAQ

Elekta (OTCMKTS:EKTAY) reported earnings of $0.11 per share for Q4 2025, missing the consensus estimate of $0.13. The report was announced on Wednesday, May 28, 2025.

Elekta reported revenue of $503.22 million for Q4 2025, against a consensus estimate of $507.19 million.

Elekta's next earnings date is estimated for Wednesday, November 25, 2026. MarketBeat tracks confirmed and estimated earnings dates for Elekta on the company's earnings history page.

Elekta Earnings Headlines

Elekta Announces Second-Quarter 2026/27 Results Presentation
November 11 at 3:11 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-announces-second-quarter-2026-27-results-presentation?utm_source=marketbeat.com&utm_medium=referral
Elekta (EKTAY) & Its Competitors Critical Contrast
November 1, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31170933
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
November 12 at 1:00 AM  |  Behind the Markets (Ad)
Elekta names investor-led Nomination Committee ahead of 2027 AGM
October 30, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-names-investor-led-nomination-committee-ahead-of-2027-agm?utm_source=marketbeat.com&utm_medium=referral
Elekta data support expanded use of Gamma Knife for multiple brain metastases
September 29, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-data-support-expanded-use-of-gamma-knife-for-multiple-brain-metastases?utm_source=marketbeat.com&utm_medium=referral
Elekta’s Unity Data Boost Pancreatic Cancer Outcomes as Unity Pro Rolls Out
September 28, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elektas-unity-data-boost-pancreatic-cancer-outcomes-as-unity-pro-rolls-out?utm_source=marketbeat.com&utm_medium=referral
See More Elekta Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elekta? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elekta and other key companies, straight to your email.

About Elekta

Elekta (OTCMKTS:EKTAY) is a Swedish medical technology company that develops equipment and software for radiation therapy and other treatments used in cancer care and neurosurgery. Founded in 1972 by neurosurgeon Lars Leksell, the company builds on his work in stereotactic radiosurgery.

Its offerings include linear accelerators for external-beam radiation therapy, systems for stereotactic radiosurgery and brachytherapy, and software that helps healthcare providers plan and manage treatment. Elekta’s technologies are used by hospitals and clinics to deliver care for cancer and certain neurological conditions.

The company serves healthcare providers in markets around the world. Its work spans equipment, treatment-planning tools, and clinical information systems designed to support radiation oncology services.

View Elekta Profile
Earnings Tools